Skip to main content
Figure 5 | Journal for ImmunoTherapy of Cancer

Figure 5

From: Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses

Figure 5

ILT2 expression by CD4+ T cell populations in non-responder and responder melanoma patients before and after rV-B7.1 treatment. (A- D) Frequency of peripheral blood cells expressing (A) FoxP3 among CD4+ T cells and ILT2 among (B) CD4+ T cells, and (C) CD4+FoxP3+ T cells was evaluated by flow cytometry in non-responder (nā€‰=ā€‰5) and responder (nā€‰=ā€‰4) metastatic melanoma patients before (pre) and after (post) intra-tumoral rV-B7.1 treatment.

Back to article page